Novel Thermoreversible Reverse-Phase-Shift Foam With Deployment System for Treatment of Penetrating Globe Trauma in a Newly Described Porcine Model.


Journal

Military medicine
ISSN: 1930-613X
Titre abrégé: Mil Med
Pays: England
ID NLM: 2984771R

Informations de publication

Date de publication:
19 Aug 2024
Historique:
received: 31 10 2023
revised: 21 12 2023
accepted: 26 02 2024
medline: 20 8 2024
pubmed: 20 8 2024
entrez: 20 8 2024
Statut: ppublish

Résumé

The initial management of penetrating ocular injuries is a major sight-threatening problem for both civilian and military medicine. A novel device (Eye-Aid) temporarily tamponades leakage from such injuries while being easy to remove upon arrival to specialized ophthalmologic care. Eye-Aid consists of a protective eye shield with an adhesive backing that connects to a portable canister containing rapidly deployable thermoresponsive foam. The aim of this study was to compare the use of the novel Eye-Aid device to control in a new live swine ocular injury model. Bilateral penetrating ocular injuries were created on 14 male Yorkshire swine in a standardized manner using a 16-gauge needle device to puncture the central cornea and cause a full-thickness wound. Researchers randomized eye intervention side, with the contralateral eye used as paired control. Two minutes after the injury, the eye shield components of the Eye-Aid system, which has a sticky pad for attachment to the skin and a luer-lock for foam deployment, were placed bilaterally. Eight minutes after the injury, foam was deployed for the intervention eye according to the device instructions for use. For the control eye, no additional procedures were performed. Six hours post-injury, end A-scan and intraocular pressure (IOP) were measured. Primary study outcome was change in axial length of the globe. Secondary outcomes were as follows: (1) Presence of full anterior chamber collapse, defined as a lack of measurable anterior lens capsule-reflex (ALC-reflex) on A-scan and (2) change in IOP. Outcomes were analyzed as paired intra-animal data, with intervention and control data for each animal. A paired t-test was used to analyze the difference in axial length change and IOP change between treatment groups, whereas a conditional logistic regression was used to analyze dichotomous ALC-reflex outcome and estimate the odds ratio associated with the Eye-Aid device. A significant difference (P < .0001) in mean change in axial length between intervention (-210 μm) and control (-1,202 μm) groups was found. There was a significant difference in ALC-reflex presence, with 79% of eyes having an ALC-reflex in the intervention group, compared to 14% in the control (P = .008). IOP remained higher in the intervention group, with a mean change of -1.5 mmHg for the intervention group compared to -4.0 mmHg in the control (P = .0001). This study describes the first development of an in vivo large animal ocular injury model that realistically approximates the emergent time course and pathophysiology of patients with full-thickness corneal open globe injuries. It also gives the first description of using thermoreversible hydrogel foam for such injuries. Eye-Aid was found to be significantly better than control for treatment of such injuries, based on measurements of both structure and pressure. Assuming that the absence of an ALC-reflex demonstrates complete anterior chamber collapse, the Eye-Aid group demonstrated a 79% eye "save" rate compared to only 14% in the control group, as described earlier. This results in a Number Needed to Treat of 3 for this finding. Eye-Aid additionally demonstrated several characteristics that would be beneficial in a device targeted for emergent deployment by non-ophthalmologists.

Identifiants

pubmed: 39160838
pii: 7735926
doi: 10.1093/milmed/usae088
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

254-261

Subventions

Organisme : U.S. Army Medical Research Acquisition Activity
ID : W81XWH-21-9-0003
Organisme : U.S. Army Medical Research Acquisition Activity
ID : W81XWH-21-9-0003

Informations de copyright

© Oxford University Press 2024.

Auteurs

Ross I Donaldson (RI)

Critical Innovations LLC, Los Angeles, CA 90260, USA.
Department of Emergency Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Department of Emergency Medicine, Harbor-UCLA Medical Center, Torrance, CA 90509, USA.
Department of Epidemiology, UCLA-Fielding School of Public Health, Los Angeles, CA 90095, USA.

Eva Chou (E)

Ophthalmology Service, Department of Surgery, Walter Reed National Military Medical Center, Bethesda, MD 20814, USA.
Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814, USA.

David A Tanen (DA)

Department of Emergency Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Department of Emergency Medicine, Harbor-UCLA Medical Center, Torrance, CA 90509, USA.

Jonathan K Armstrong (JK)

Critical Innovations LLC, Los Angeles, CA 90260, USA.

Oliver J Buchanan (OJ)

Critical Innovations LLC, Los Angeles, CA 90260, USA.

Todd L Graham (TL)

Benchmark Biotech LLC, Portland, OR 97206, USA.

Nely N Cristerna (NN)

Critical Innovations LLC, Los Angeles, CA 90260, USA.

John S Cambridge (JS)

Critical Innovations LLC, Los Angeles, CA 90260, USA.

Diane Goldenberg (D)

Critical Innovations LLC, Los Angeles, CA 90260, USA.

Juliana Tolles (J)

Department of Emergency Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Department of Emergency Medicine, Harbor-UCLA Medical Center, Torrance, CA 90509, USA.

James D Ross (JD)

Benchmark Biotech LLC, Portland, OR 97206, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH